Pfizer (NYSE:PFE) Price Target Cut to $45.00

Pfizer (NYSE:PFE – Get Rating) had its target price cut by Bank of America from $50.00 to $45.00 in a research report released on Friday morning, The Fly reports. They currently have a neutral rating on the biopharmaceutical company’s stock. A number of other equities analysts also recently issued reports on PFE. Daiwa Capital Markets […]

Related Keywords

United States ,America , ,Pfizer ,Mendota Financial Group ,Jefferies Financial Group ,Lam Group Inc ,My Personal ,Karp Capital Management Corp ,Securities Exchange Commission ,Pfizer Inc ,Worth Asset Management ,Get Rating ,Capital Markets ,Exchange Commission ,Asset Management ,Capital Management Corp ,Pfizer Daily ,Nyse Pfe ,Pfe ,Medical ,71708110 ,Lower Price Target ,Bank Of America Co ,